SEC-sourced researchBeta
VYCO
VYCOR MEDICAL INC
Company comparison ↗
Data passport
- CIK
- 0001424768
- Exchange
- OTC
- Business activity
- — · SIC 3841
- Financial inputs
- 6/6
- Filing date
- Mar 31, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 1,589,324.0000 | Mar 31, 2026 |
| December 2025 | 1,863,400.0000 | Mar 31, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 1,863,400.0000 | -72,426.0000 | -13,471.0000 | 830,420.0000 | 4,917,299.0000 | Mar 31, 2026 |
| December 2024 | 1,589,324.0000 | -107,200.0000 | 60,110.0000 | 998,117.0000 | 4,688,200.0000 | Mar 31, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.86M | December 2025 | Mar 31, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.59M | December 2024 | Mar 31, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$72.43K | December 2025 | Mar 31, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$13.47K | December 2025 | Mar 31, 2026 | 10-K |
| Total assetsAssets | $830.42K | December 2025 | Mar 31, 2026 | 10-K |
| Total liabilitiesLiabilities | $4.92M | December 2025 | Mar 31, 2026 | 10-K |